Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Operating Margin: 2011-2025

Historic Operating Margin for Fennec Pharmaceuticals (FENC) over the last 5 years, with Sep 2025 value amounting to -1.52%.

  • Fennec Pharmaceuticals' Operating Margin rose 7307.00% to -1.52% in Q3 2025 from the same period last year, while for Sep 2025 it was -12.02%, marking a year-over-year decrease of 1543.00%. This contributed to the annual value of 5.40% for FY2024, which is 6550.00% up from last year.
  • According to the latest figures from Q3 2025, Fennec Pharmaceuticals' Operating Margin is -1.52%, which was up 94.64% from -28.31% recorded in Q2 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Operating Margin peaked at 123,075.00% during Q1 2021, and registered a low of -314.25% during Q1 2023.
  • Its 3-year average for Operating Margin is -57.23%, with a median of -18.67% in 2023.
  • Per our database at Business Quant, Fennec Pharmaceuticals' Operating Margin tumbled by 11,696,121bps in 2022 and then soared by 36,841bps in 2024.
  • Quarterly analysis of 5 years shows Fennec Pharmaceuticals' Operating Margin stood at 7,587.27% in 2021, then tumbled by 94,946bps to 1,047.37% in 2022, then tumbled by 106,605bps to -18.67% in 2023, then skyrocketed by 689bps to -11.79% in 2024, then soared by 7,307bps to -1.52% in 2025.
  • Its Operating Margin stands at -1.52% for Q3 2025, versus -28.31% for Q2 2025 and -9.23% for Q1 2025.